
Clocks across the majority of European countries are set to go forward by one hour early on Sunday as the continent moves to daylight saving time, also known as summer time.
Clocks in most European nations including Germany advance by one hour at 2 am (0100 GMT) to 3 am, heralding longer evenings and brighter days.
This means that for the coming months parts of Europe will be on Central European Summer Time (CEST), before moving back to Central European Time (CET) in the autumn, when clocks go back again by an hour on October 25.
The aim of the change is to make better use of daylight in the shorter days of the winter in the northern hemisphere.
The signal for the automatic changeover of the clocks in Germany comes from the Federal Institute of Physics and Metrology (PTB) in the northern city of Braunschweig, also known as Brunswick in English.
The institute's experts ensure that radio-controlled clocks, station clocks and many industrial clocks are supplied with the signal via a long-wave transmitter called DCF77 in Mainflingen near Frankfurt.
LATEST POSTS
- 1
Israel says it killed armed Hamas 'terrorists' in Gaza - 2
FDA official discusses potential link between COVID-19 vaccines and pediatric deaths - 3
Find Successful Magnificence Items for Sparkling Skin - 4
Exemplary Fragrances: A Manual for Notorious Scents - 5
ByHeart infant formula recall tied to botulism outbreak puts parents on edge
5 Great Crossover Vehicles For Eco-friendliness In 2024
Concern for couple jailed in Tehran as British embassy closes
UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
Help Your Insusceptibility: Good dieting and Way of life Tips
'Euphoria' releases Season 3 photos with Zendaya, Sydney Sweeney, Jacob Elordi and others: See them
Remains of banker missing since 1999 found on California beach by family looking for seashells
Iran-backed Iraqi militias attack Kurdistan over 450 times since beginning of war
See as Your #1: These Low-Sugar Food sources You Ought to Attempt
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug












